Glaxo Wellcome Lamictal
Executive Summary
Lamotrigine tablets and dispersible tablets approved for "conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing anti-epileptic drug" Dec. 14. Lamictal was previously approved for adjunctive therapy only